Respiratory & Sleep Diagnostics Department, Connolly Hospital
Dublin, D15, Ireland
NCT Number: NCT02521532
Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in obstructive sleep apnea syndrome (OSAS) has not been reported.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Dublin, D15, Ireland
Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in OSAS has not been reported.
The investigators hypothesize that chronic nitrate consumption might increase exercise tolerance, and exhaled NO but decrease blood pressure and have little impact on quality of life and pulmonary function.
This study is a randomized, double-blind placebo-controlled, crossover trial. At baseline, mid-point and endpoint exercise tolerance, pulmonary function, quality of life and ambulatory blood pressure will be assessed in conjunction with demographics and blood draw. After baseline measures, each subject will be randomized to consume nitrate rich beetroot juice for 14 consecutive nights when assessments will be repeated followed by 14 nights of placebo and endpoint assessments or the converse.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects.
Other names: Beetroot juice
140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects.
Other names: Nitrate depleted beetroot juice
Time frame: Day 1, day 15 and day 29
Time frame: Day 1, day 15 and day 29
Assessed by chemiluminescence
Time frame: Day 1, day 15 and day 29
Time frame: Day 1, day 15 and day 29
Quality of Life will be assessed with the Clinical COPD Questionnaire
Time frame: Day 1, day 15 and day 29
Assessed by spirometry
Time frame: Day 1, day 15 and day 29
Assessed by C-reactive protein
Time frame: Day 1, day 15 and day 29
Assessed by spirometry
Time frame: Day 1, day 15 and day 29
Assessed by chemiluminescence
Royal College of Surgeons, Ireland
Other
Dietary Nitrate for COPD: a 14d, Randomized, Placebo-controlled, Crossover Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05984823
Chronic Disease, Chronic Obstructive Pulmonary Disease
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT05572333
COPD, Chronic Disease
Frankfurt, Germany
View Trial DetailsNCT03641235
Chronic Disease, Chronic Obstructive Pulmonary Disease
Bordeaux, France
View Trial DetailsNCT05984680
Chronic Disease, Chronic Obstructive Pulmonary Disease
Winston-Salem, North Carolina, United States
View Trial Details